The Effect of Virtual Reality Glasses on Pain on Intravenous Cannulatıon in Children

Pain, Procedural Clinical Trial

Official title:

A Technological Intervention in Pain Control on Intravenous Cannulatıon in Children Virtual Reality Glasses: A Randomized Controlled Study

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT05273866
• Other study ID #: 84902927
• Status: Completed
• Phase: N/A
• Start date: April 29, 2019
• Est. completion date: August 31, 2019

Study information

• Verified date: March 2022
• Source: Nevsehir Haci Bektas Veli University
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

This study was carried out to determine the effect of virtual reality glasses on reducing pain during vascular access in children. The study consisted of 70 children (35 children in the virtual reality video group and 35 children in the control group). Ethics committee approval, permissions from institutions and informed voluntary consent of the children were obtained in order to conduct the study. The data of the study were collected with Child Descriptive Characteristics Form, Parent Descriptive Characteristics Form, Visual Analog Scale (VAS), Revised Facial Expression Pain Scale (FPS-R), Intervention Monitoring Form, Child Behavior Observation Form and Parent Behavior Observation Form. In the study, the children in the experimental group were shown a video with virtual reality glasses during the vascular access procedure. Before and after the study; The child and his parents were asked to evaluate the pain experienced/will experience during the procedure, the children's heart rate, O2 saturation, body temperature were measured, and the behaviors of the child and the parent during the procedure were evaluated. A p value of <0.05 was considered statistically significant in data analysis.

Description:

This randomized controlled experimental study was conducted to determine the effect of virtual reality glasses on reducing pain during vascular access in children. The study was conducted among children aged 7-12 years in a tertiary hospital. Children in the experimental group (n=35) and control group (n=35); Age, gender, class of education, previous hospitalization and vascular access experience criteria were selected similar (p>0.05). Data were collected with Child Descriptive Characteristics Form, Parent Descriptive Characteristics Form, Visual Analog Scale (VAS), Revised Facial Expression Pain Scale (FPS-R), Intervention Monitoring Form, Child Behavior Observation Form, and Parent Behavior Observation Form. In the study, the children in the experimental group were shown a video with virtual reality glasses during the vascular access procedure. Before and after the study; The child and his parents were asked to evaluate the pain experienced/will experience during the procedure, the children's heart rate, O2 saturation, body temperature were measured, and the behaviors of the child and the parent during the procedure were evaluated. Data were used post-power analysis, descriptive statistics, Shapiro Wilk, Pearson chi-square, Mann Whitney U and Two-Related-Samples Tests. A p value of <0.05 was considered statistically significant in data analysis.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 70
• Est. completion date: August 31, 2019
• Est. primary completion date: August 31, 2019
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: All
• Age group: 7 Years to 12 Years

Eligibility

Inclusion Criteria:

• between the ages of 7-12,

• Does not have a disease that causes chronic pain,

• Not taking any analgesic medication in the last 8 hours before the procedure,

• No mental or neurological disability,

• Having no visual or auditory problems that prevent you from applying the scales or watching videos,

• Does not have eye problems and/or does not use glasses to be able to wear VR glasses,

• The first vascular access procedure was performed during this hospitalization at the clinic,

• Vascular access opened on the first try,

• Speaking and understanding Turkish,

• Children whose parents and themselves agreed to participate in the study were included in the study.

Exclusion Criteria:

• Does not understand the Turkish language

• the child is under 7 years old or 12 years older

• having vision, hearing or speech problems

• having a mental or neurological disability

Related Conditions & MeSH terms

• Pain, Procedural

Intervention

Other:
• Virtual reality
Virtual Reality video application reduces pain by distracting. The intervention group was watched video during the procedure, starting before the procedure.

Locations

Country	Name	City	State
Turkey	Bahriye Kaplan	Nevsehir

Sponsors (1)

Lead Sponsor	Collaborator
Nevsehir Haci Bektas Veli University

Country where clinical trial is conducted

Turkey, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Visual Analog Scale (VAS), Change:	The severity of the pain marked by the child on the scale ranges from 0 to 10. If the severity increases after the procedure, it indicates that the pain increases, and if it decreases, it indicates that the pain decreases.	2 minutes before and 2 minutes after Intravenous Cannulation
Primary	Faces Pain Scale-Revised (FPS-R), Change:	In the scale consisting of facial expressions, each facial expression has a number equivalent. The severity of pain marked by the child on the scale ranges from 0 to 10. If the severity increases after the procedure, it indicates that the pain increases, and if it decreases, it indicates that the pain decreases.	3 minutes before and 3 minutes after Intravenous Cannulation
Secondary	Physiological parameters	Heart Rate, Change	2 minutes before and 2 minutes after Intravenous Cannulation
Secondary	Physiological parameters	Oxygen saturation, Change	3 minutes before and 3 minutes after Intravenous Cannulation